Day One Welcome

View Session

Optimising Large-Bore Venous Closure: PerQseal® Elite in Real-World Practice

Breakout

Chair: Vasileios Panoulas, London, UK

Panel: Rutger-Jan Nuis, Rotterdam, NL; Mohamed Abdel-Wahab, Leipzig, DE

• Introduction and Session Objectives – Vasileios Panoulas

• The Evolving Landscape of Large-Bore Venous Closure – Vasileios Panoulas

• PerQseal® Elite: Innovation and Clinical Evidence – Rutger-Jan Nuis

• Case-Based Discussion: Practical Tips for PerQseal® Elite – Mohamed Abdel-Wahab

• Closing Remarks and Q&A – All Faculty

 

This breakout is supported by Vivasure Medical

View Session

Session 1.1

Upstream TAVR Has Arrived, Should Guidelines Follow?

Chair: Nicolas Van Mieghem, Rotterdam, NL and Ole De Backer, Copenhagen, DK

Panel: Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT

• Moderate AS - What’s Next After TAVR UNLOAD – Nicolas Van Mieghem

• Asymptomatic Severe AS – A Home Run – Nicolas Van Mieghem

• Pure Aortic Regurgitation – A Legitimate TAVR Target? – Thomas Modine

 

View Session

Session 1.2

Live Cases

Chair: Ole De Backer, Copenhagen, DK

Panel: Sabine Bleiziffer, Bad Oeynhausen, DE; Thomas Modine, Bordeaux, FR; Giuseppe Tarantini, Padua, IT

• Pure Aortic Regurgitation Case – Nicolas Van Mieghem, Erasmus MC, Rotterdam, NL

• TAVR-in-TAVR Case – Holger Thiele and Mohamed Abdel-Wahab, Leipzig Heart Center, Leipzig, DE

The live case from Leipzig Heart Center is powered by Medinbox®

View Session

TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management

Symposium

Chair: Rui Teles, Carnaxide, PT

Panel: James Cockburn, Brighton, UK; Birgid Gonska, Bad Nauheim, DE; Vlasis Ninios, Thessaloniki, GR

Case Operator: Won-Keun Kim, University of Giessen & Marburg, Giessen, DE

• Welcome and Introduction – Rui Teles, Carnaxide, PT

• TAVI Procedure Optimisation: Lessons From the ACURATE IDE Study – James Cockburn, Brighton, UK

• Enhancing TAVI Outcomes: Precise Valve Placement and Implantation – Birgid Gonska, Bad Nauheim, DE

• Implications of Index Procedure Outcomes on Lifetime Patient Management – Vlasis Ninios, Thessaloniki, GR

• Case in Focus: TAVI for Larger Annuli Patients  – Won-Keun Kim, Giessen, DE

• Panel Discussion and Q&A – All

 

This symposium is supported by an unrestricted educational grant from Boston Scientific.

*TAVI Index Procedure: The Value of Valve Optimisation on Long-term Outcomes and Lifetime Management has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hour of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

View Session

Session 1.3

Atrioventricular Valves

Chair: Azeem Latib, New York, US

Panel: Adam Greenbaum, Atlanta, US; David Hildick-Smith, Brighton, UK; Philipp Lurz, Mainz, DE; Thomas Modine, Bordeaux, FR

• A Plea for Upstream Secondary MR Treatment – Philipp Lurz

• The Importance of Complete Elimination of TR – Adam Greenbaum

• How Strongly Do We Need to Recommend Transcatheter LAA Closure – David Hildick-Smith

 

View Session

Session 1.4

Live Cases

Chair: Azeem Latib, New York, US

Panel: Adam Greenbaum, Atlanta, US; David Hildick-Smith, Brighton, UK

• TTVR Case – Philipp Lurz, University Medical Center Mainz, Mainz, DE

• TTVR Case – Thomas Modine, Bordeaux University Hospital, Bordeaux, FR

The live cases from University Medical Center Mainz and Bordeaux University Hospital are powered by Medinbox®

View Session

Day One Close

View Session